A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer

Grzegorz S. Nowakowski, Andrea K. McCollum, Matthew M. Ames, Sumithra J. Mandrekar, Joel M. Reid, Alex A. Adjei, David O. Toft, Stephanie L. Safgren, Charles Erlichman

Research output: Contribution to journalArticle

101 Scopus citations

Fingerprint Dive into the research topics of 'A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences